Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Bioprinting "Track B"

Michael Gelinsky's Biography



Michael Gelinsky, Professor and Head, Center for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden

Michael Gelinsky received his PhD in Chemistry from Freiburg University (Germany). In 1999 he moved to TU Dresden and worked for around 10 years at the department of Materials Science, heading his own group at the newly founded Max Bergmann Center of Biomaterials from 2002. In 2010 he was appointed Full Professor at the Faculty of Medicine and head of the Centre for Translational Bone, Joint and Soft Tissue Research (tu-dresden.de/med/tfo). His work is focused on biomaterials and scaffold development, tissue engineering and regenerative therapies, mostly for musculoskeletal tissues. His group is also very active in the field of additive manufacturing of implants and biofabrication technologies. Michael Gelinsky is currently President of the German Society for Biomaterials, is a member of the Board of Directors of the International Society for Biofabrication (ISBF) and has been appointed as coordinator of an ESA Topical Team on “3D Bioprinting of living tissue for utilization in space exploration and extraterrestrial human settlements”. He also is member of the ESA Facility Science Team (FST) for the development of a bioprinter and 3D cell culture system for the ISS.

Michael Gelinsky Image

Novel Materials and Strategies For Extrusion Bioprinting

Thursday, 4 October 2018 at 16:00

Add to Calendar ▼2018-10-04 16:00:002018-10-04 17:00:00Europe/LondonNovel Materials and Strategies For Extrusion BioprintingSELECTBIOenquiries@selectbiosciences.com

Three dimensional bioprinting is a fast developing field of research. Beside other technologies, extrusion printing (direct printing/3D plotting) is one of the most common techniques for bioprinting. It is based on the controlled deposition of cells, suspended in hydrogels of suitable viscosity. The combination of hydrogel and cells is called bioink. Extrusion bioprinting therefore directly leads to tissue-like constructs, consisting of cells and an extracellular matrix-like structure which might be advantageous especially for musculoskeletal tissues. The lecture will describe some recent developments in the field of novel bioinks, co-printing of bioinks and self-setting mineral bone cements as well as a nanoparticle-based sensor system which allows local on-line analysis of oxygen concentration in 3D bioprinted constructs.


Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/London3D-Bioprinting "Track B"SELECTBIOenquiries@selectbiosciences.com